Testing a diabetes pill under the tongue for type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This early-phase study tests the safety and side effects of liraglutide taken under the tongue, and looks for early signs it improves blood sugar in people with type 2 diabetes. It may help people who want an alternative way to get this medication, but the main goal is to see how safe and tolerable it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 65 years old
- Have type 2 diabetes for at least 1 year
- Have body weight in a BMI range of 18 to 35
- Have blood sugar and diabetes test results in these ranges (HbA1c 6.5% to 9.0%)
- Be on a stable diabetes plan: usually stable metformin for at least 2 months, or diet/exercise only with stable HbA1c
- Have heart tests and blood pressure that are within allowed limits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational pill for people with type 2 diabetes whose blood sugar is not well controlled despite lifestyle changes or metformin. The pill may help improve blood sugar control and is taken by mouth.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.
This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.
This trial tests a combination of three diabetes medicines (dapagliflozin, linagliptin, and metformin) in healthy adults to see how safe they are and how the body processes them. Participating could help make sure these medicines are safe for people with diabetes.
This study tests a new once-every-2-weeks pill (cofrogliptin) added to your current diabetes medications (metformin and dapagliflozin) compared to a daily pill (linagliptin). It may help improve blood sugar control with fewer daily pills.
Hear when a new Diabete Type 2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.